← FDA DRUG APPROVALS

FDA ANDA · ANDA085756

CAM-METRAZINE

Sponsor: CAMALL

APPLICATION
ANDA085756
TYPE
ANDA
ORIGINAL APPROVAL
1977-05-11
LATEST ACTION
1988-11-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CAM-METRAZINEDiscontinued
PHENDIMETRAZINE TARTRATE 35MG · TABLET · ORAL

Approval history

1988-11-09Labeling · Supplement 18AP
1988-06-27Manufacturing (CMC) · Supplement 16AP
1984-05-24Manufacturing (CMC) · Supplement 14AP
1983-06-07Manufacturing (CMC) · Supplement 13AP
1983-06-03Manufacturing (CMC) · Supplement 10AP
1977-05-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →